查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1685214

心電圖 (ECG) 設備市場機會、成長動力、產業趨勢分析與預測 2025 - 2034

Electrocardiogram (ECG) Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 158 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球心電圖設備市場價值為 77 億美元，預計 2025 年至 2034 年的複合年成長率為 4.2%。心臟病、心律不整和高血壓等心血管疾病仍是全球主要的健康挑戰，推動了對心電圖設備的需求。這些疾病是全球主要死亡原因之一，凸顯了早期發現和持續監測的必要性。人口老化更容易出現心臟相關併發症，在推動市場成長方面發揮重要作用。

心電圖 (ECG) 設備市場 - IMG1

世界各國政府都將心血管疾病的早期發現和管理放在首位，同時增加醫療支出以支持先進醫療技術的發展。人們對心臟健康的認知也日益增強，促使人們轉向預防保健和定期心臟檢查。心電圖設備的不斷進步，例如增強的數位連接和改進的診斷演算法，使其在各種醫療保健環境中（包括醫院、診斷中心和家庭醫療保健）越來越容易使用和有效。更廣泛的可用性和增強的功能是市場擴張的主要驅動力。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 77億美元
預測值 116億美元
複合年成長率 4.2％

就產品類型而言，心電圖設備市場主要分為診斷心電圖機和監測心電圖設備。診斷性心電圖機器市場預計將以 3.7% 的複合年成長率成長，到 2034 年將達到 61 億美元。這些機器在檢測心臟異常方面發揮著至關重要的作用，使醫療保健提供者能夠高精度地評估心臟活動。與老化相關的慢性病發生率不斷上升是推動診斷機器需求的重要因素。同時，多導線配置和數位整合等持續的技術改進正在提高其在臨床環境中的效率和準確性，簡化工作流程並改善患者的治療效果。

依導聯類型細分，心電圖設備市場分為單導極、3 導聯、6 導聯、12 導聯和其他導聯類型。 12 導程心電圖市場表現突出，預計複合年成長率為 4.7%，到 2034 年將達到 53 億美元。該市場因其全面評估心臟活動的能力而佔據主導地位，對於診斷複雜的心血管疾病必不可少。醫療保健專業人員高度依賴 12 導程心電圖的準確性和心律詳細分析，尤其是在緊急和重症監護環境中。這些設備對於重症監護室和心臟監測中心至關重要，因為它們具有廣泛的診斷能力，可確保精確監測心臟健康。

在美國，心電圖設備市場在 2024 年的價值為 24 億美元，預計到 2034 年的複合年成長率為 3.8%。心血管疾病的持續高發生率繼續推動對心電圖設備的需求，因為早期診斷和持續監測對於管理心臟病至關重要。美國正在經歷人口老化，更容易罹患慢性心臟病，進一步刺激市場需求。憑藉強大的醫療保健基礎設施和持續的技術進步，美國有能力引領全球市場。隨著對創新心電圖解決方案的投資增加和患者意識的提高，美國市場將在未來幾年繼續成長。

目錄

第 1 章：方法論與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業衝擊力
    • 成長動力
      • 心血管疾病盛行率不斷上升
      • 心電圖設備的技術進步
      • 行動和遙測心臟監視器的普及率不斷提高
      • 心臟健康意識不斷增強
    • 產業陷阱與挑戰
      • 先進心電圖設備成本高昂
      • 缺乏熟練的專業人員
  • 成長潛力分析
  • 監管格局
  • 技術格局
  • 差距分析
  • 波特的分析
  • PESTEL 分析
  • 未來市場趨勢
  • 穿戴式心電圖設備對陣發性心臟相關症狀患者實用性的概述
  • 臨床環境下手持式心電圖設備的開發
  • 用於運動時心電圖監測的軟性穿戴電極的開發

第4章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 策略儀表板

第5章：市場估計與預測：按產品，2021 — 2034 年

  • 主要趨勢
  • 診斷心電圖機
    • 靜止心電圖
    • 壓力心電圖
  • 監測心電圖設備
    • 動態心電圖監測
    • ECG遙測監測/事件監測
    • 植入式心臟監測儀
    • 其他監測心電圖設備

第6章：市場估計與預測：依線索類型，2021 年至 2034 年

  • 主要趨勢
  • 單引線型
  • 3 引線類型
  • 6 引線類型
  • 12 引線型
  • 其他引線類型

第 7 章：市場估計與預測：按便攜性，2021 年至 2034 年

  • 主要趨勢
  • 非攜帶式設備
  • 攜帶式設備

第 8 章：市場估計與預測：依最終用途，2021 年至 2034 年

  • 主要趨勢
  • 醫院和診所
  • 門診手術中心
  • 診斷中心
  • 居家照護環境
  • 其他最終用戶

第 9 章：市場估計與預測：按地區，2021 年至 2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第10章：公司簡介

  • ALIVECOR
  • Allengers
  • biotricity
  • bionet
  • BIOTRONIK
  • Boston Scientific
  • BPL Medical Technologies
  • CARDIOLINE
  • FUKUDA
  • GE HealthCare
  • Baxter
  • PHILIPS
  • Medtronic
  • mindray
  • SPACELABS HEALTHCARE
簡介目錄
Product Code: 5425

The Global Electrocardiogram Devices Market, valued at USD 7.7 billion in 2024, is expected to expand at a CAGR of 4.2% from 2025 to 2034. Cardiovascular diseases, including heart attacks, arrhythmias, and hypertension, continue to be major health challenges worldwide, driving the demand for ECG devices. These conditions are among the leading causes of death globally, highlighting the need for early detection and continuous monitoring. The aging population, which is more prone to heart-related complications, plays a significant role in boosting market growth.

Electrocardiogram (ECG) Devices Market - IMG1

Governments worldwide are prioritizing early detection and management of cardiovascular diseases, while healthcare expenditures rise to support the development of advanced medical technologies. There is also growing awareness about heart health, prompting a shift toward preventive care and regular cardiac screenings. Continuous advancements in ECG devices, such as enhanced digital connectivity and improved diagnostic algorithms, are making them increasingly accessible and effective across various healthcare settings, including hospitals, diagnostic centers, and home healthcare. This broader availability and enhanced functionality are key drivers of market expansion.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$ 7.7 Billion
Forecast Value$ 11.6 Billion
CAGR4.2%

In terms of product types, the ECG devices market is primarily divided into diagnostic ECG machines and monitoring ECG devices. The diagnostic ECG machines segment is set to grow at a CAGR of 3.7%, reaching USD 6.1 billion by 2034. These machines play a crucial role in detecting cardiac abnormalities, allowing healthcare providers to assess heart activity with high precision. The increasing prevalence of chronic conditions related to aging is a significant factor driving the demand for diagnostic machines. At the same time, continuous technological improvements, such as multi-lead configurations and digital integration, are enhancing their efficiency and accuracy in clinical settings, streamlining workflows and improving patient outcomes.

When broken down by lead type, the ECG devices market is categorized into single-lead, 3-lead, 6-lead, 12-lead, and other lead types. The 12-lead ECG segment stands out, projected to grow at a CAGR of 4.7%, reaching USD 5.3 billion by 2034. This segment dominates due to its comprehensive ability to assess the heart's activity, making it indispensable for diagnosing complex cardiovascular conditions. Healthcare professionals rely heavily on 12-lead ECGs for their accuracy and detailed analysis of heart rhythms, especially in emergency and critical care settings. These devices are vital in intensive care units and cardiac monitoring centers due to their extensive diagnostic capabilities, ensuring precise monitoring of heart health.

In the United States, the ECG devices market was valued at USD 2.4 billion in 2024, with expectations to grow at a CAGR of 3.8% through 2034. The persistent high prevalence of cardiovascular diseases continues to drive the demand for ECG devices, as early diagnosis and continuous monitoring are crucial for managing heart conditions. The U.S. is also witnessing an aging population that is more susceptible to chronic heart diseases, further fueling market demand. With its robust healthcare infrastructure and ongoing technological advancements, the U.S. is well-positioned to lead the global market. As investments in innovative ECG solutions rise and patient awareness improves, the U.S. market is set for continued growth in the coming years.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of cardiovascular diseases
      • 3.2.1.2 Technological advancements in ECG devices
      • 3.2.1.3 Increasing adoption of mobile and telemetry cardiac monitors
      • 3.2.1.4 Rising awareness about heart health
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of advanced ECG devices
      • 3.2.2.2 Lack of skilled professionals
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Gap analysis
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis
  • 3.9 Future market trends
  • 3.10 Overview on usefulness of wearable ECG devices in patients experiencing paroxysmal cardiac-related symptoms
  • 3.11 Development of a handheld electrocardiogram device in a clinical setting
  • 3.12 Development of flexible wearable electrodes for electrocardiogram monitoring during exercise

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 — 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Diagnostics ecg machines
    • 5.2.1 Resting ecg
    • 5.2.2 Stress ecg
  • 5.3 Monitoring ecg devices
    • 5.3.1 Holter monitoring
    • 5.3.2 ECG telemetry monitoring/Event monitoring
    • 5.3.3 Implantable cardiac monitors
    • 5.3.4 Other monitoring ecg devices

Chapter 6 Market Estimates and Forecast, By Lead Type, 2021 — 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Single lead type
  • 6.3 3 lead type
  • 6.4 6 lead type
  • 6.5 12 lead type
  • 6.6 Other lead types

Chapter 7 Market Estimates and Forecast, By Portability, 2021 — 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Non-portable device
  • 7.3 Portable device

Chapter 8 Market Estimates and Forecast, By End Use, 2021 — 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals and clinics
  • 8.3 Ambulatory surgical centers
  • 8.4 Diagnostic centers
  • 8.5 Home care settings
  • 8.6 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2021 — 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 ALIVECOR
  • 10.2 Allengers
  • 10.3 biotricity
  • 10.4 bionet
  • 10.5 BIOTRONIK
  • 10.6 Boston Scientific
  • 10.7 BPL Medical Technologies
  • 10.8 CARDIOLINE
  • 10.9 FUKUDA
  • 10.10 GE HealthCare
  • 10.11 Baxter
  • 10.12 PHILIPS
  • 10.13 Medtronic
  • 10.14 mindray
  • 10.15 SPACELABS HEALTHCARE